Volume 4, Issue 3 ( Journal of Clinical and Basic Research (JCBR) 2020)
jcbr 2020, 4(3): 10-14 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hoseini H, Etemadi S. Evaluation of Redox Status in Patients with Hepatitis B Virus in Zahedan, Iran. jcbr 2020; 4 (3) :10-14
URL: http://jcbr.goums.ac.ir/article-1-264-en.html
URL: http://jcbr.goums.ac.ir/article-1-264-en.html
1- Department of Laboratory Sciences, Zahedan Branch, Islamic Azad University, Zahedan , Iran
2- Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
2- Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
Abstract: (2580 Views)
Background and objectives: Redox status can be defined as an increase in oxidant and/or a decrease in antioxidant capacities. There is limited information about the redox status of patients with hepatitis B virus (HBV) infection. Therefore, we aimed to evaluate the redox status of patients with HBV infection in Zahedan, Southeast of Iran.
Methods: This study was carried out in 2019 on 25 HBV patients and 25 healthy individuals. The level of malondialdehyde (MDA) was measured as a marker of lipid peroxidation. Superoxide dismutase (SOD) activity was also measured. Data were analyzed using SPSS software (version 17) at significance of 0.05.
Results: The MDA level in patients (5.3 ± 2.511 n/ml) was significantly higher than in controls (3.48 ± 0.516 n/ml) (P <0.01). Moreover, SOD activity was significantly lower in HBV patients (125.05±55.545 n/μl) compared to healthy controls (271 ± 74.236 n/μl) (P<0.01).
Conclusion: Our results show that patients with HBV infection have higher serum MDA level and lower SOD activity compared to healthy individuals. This can cause liver damage and aggravate the complications in hepatitis B patients
Methods: This study was carried out in 2019 on 25 HBV patients and 25 healthy individuals. The level of malondialdehyde (MDA) was measured as a marker of lipid peroxidation. Superoxide dismutase (SOD) activity was also measured. Data were analyzed using SPSS software (version 17) at significance of 0.05.
Results: The MDA level in patients (5.3 ± 2.511 n/ml) was significantly higher than in controls (3.48 ± 0.516 n/ml) (P <0.01). Moreover, SOD activity was significantly lower in HBV patients (125.05±55.545 n/μl) compared to healthy controls (271 ± 74.236 n/μl) (P<0.01).
Conclusion: Our results show that patients with HBV infection have higher serum MDA level and lower SOD activity compared to healthy individuals. This can cause liver damage and aggravate the complications in hepatitis B patients
Article Type: Research |
Subject:
Basic medical sciences
References
1. Halegoua-De Marzio D, Hann HW. Then and now: the progress in hepatitis B treatment over the past 20 years. World J Gastroenterol. 2014;20(2):401-13.doi: 10.3748/wjg.v20.i2.401.[PubMed: 24574709]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
2. McCluneAC,TongMJ.Chronic hepatitis Band hepatocellular carcinoma.ClinLiverDis. 2010;14(3):461-76.doi:10.1016/j.cld.2010.05.009. [PubMed: 20638025]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
3. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2014;132(7):2557- 76.doi: 10.1053/j.gastro.2014.04.061.[PubMed: 17570226]. [View at Publisher] [DOI] [Google Scholar]
4. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B.Aliment Pharmacol Ther. 2011;34(10):1145-58.doi: 10.1111/j.1365-2036.2011.04869.x.[PubMed: 21978243]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
5. Santantonio TA, Fasano M. Chronic hepatitis B: Advances in treatment. World J Hepatol. 2014;6(5):284-92. doi: 10.4254/wjh.v6.i5.284. [PubMed: 24868322]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
6. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalya- naraman B, Finkel T, et al. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med. 2015;45(1):1-17. doi: 10.1016/j.freeradbiomed.2015.03.011. [PubMed: 18423411]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
7. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2014;108(16):1912-6. doi: 10.1161/01.CIR.0000093660.86242.BB.[PubMed: 14568884]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
8. Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:137289. doi: 10.5402/2012/137289.[PubMed: 23119185]. [DOI] [PubMed] [Google Scholar]
9. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2013;15(4):316-28. doi: 10.1016/j.numecd.2013.05.003.[PubMed: 16054557]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
10. Dikici I, Mehmetoglu I, Dikici N, Bitirgen M, Kurban S. Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-alpha treatment. Clin Biochem. 2016;38(12):1141-4. doi: 10.1016/j.clinbiochem.2016.10.006.[PubMed: 16300751]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
11. Sen V, Uluca U, Ece A, Kaplan I, Bozkurt F, Aktar F, et al. Serum prolidase activity and oxidant-antioxidant status in children with chronic hepatitis B virus infection. Ital J Pediatr. 2014;40:95. doi: 10.1186/s1305-2014-0095-1.[PubMed: 25425101]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
12. Tsai SM, Lin SK, Lee KT, Hsiao JK, Huang JC, Wu SH, et al. Evaluation of redox statuses in patients with hepatitis B virus associated hepatocellular carcinoma.AnnClinBiochem. 2012;46(Pt5):394-400.doi: 10.1258/acb.2012.009029.[PubMed: 19641006]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
13. Karsen H, Binici I, Sunnetcioglu M, Baran AI, Ceylan MR, Selek S, et al. Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B. Afr Health Sci. 2012;12(2):114-8. doi: 10.4314/ahs.v12i2.6.[PubMed: 23056015]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
14. DuyguF,KarsenH,AksoyN,TaskinA.Relationship of oxidative estress in hepatitis B infection activity with HBV DNA and fibrosis. Ann Lab Med. 2012;32(2):113-8. doi: 10.3343/alm.2012.32.2.113. [PubMed: 22389877]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
15. Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol. 2014;97(10):2634-9. doi: 10.1111/j.1572-0241.2014.06041.x. [PubMed: 12385452]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
16. Severi T, Ying C, Vermeesch JR, Cassiman D, Cnops L, Verslype C, et al. Hepatitis B virus replication causes oxidative stress in HepAD38 livercells.MolCellBiochem. 2013;290(1-2):79-85.doi:10.1007/s11010-2 013-9167-x.[PubMed: 16960659]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
17. Abel S, De Kock M, van Schalkwyk DJ, Swanevelder S, Kew MC, Gelderblom WC. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins Leukot Essent Fatty Acids. 2015;81(5-6):391-9. doi: 10.1016/j.plefa.2015.08.003.[PubMed: 19782547]. [View at Publisher] [DOI] [PubMed] [Google Scholar]
18. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV: Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B. 2012;101(7-9):591-8. doi: 10.1111/1671-1245.2012.08.003.[PubMed: 15637859]. [View at Publisher] [PubMed] [Google Scholar]
19. Kökoğlu f, Ratziu V, Giral P, Charlottes F, Beucler I, Poynard T. Blood oxidative stress markers are unreliable markers of hepatic steatosis. 2015;101(9-11):591-8. doi: 10.3451/1671-1245.2015.11.003.[PubMed: 75937859]. [View at Publisher] [PubMed] [Google Scholar]
20. Kaya S, Sutcu R, Cetin ES, Yılmaz N, Arıkan S, Arıdogan BC. Relationship Between Viral Load and Lipid Peroxidation and Antioxidant Enzymes in Patients Infected with Hepatitis B Virus. Mikrobiyol Bul. 2013;50:55. doi: 10.1373/s1305-2013-0095-1.[PubMed: 10125254]. [View at Publisher] [Google Scholar]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).